September 26, 2018 September 26, 2018Brammer Bio announces progress on $200 million program to advance gene therapies
September 4, 2018 September 4, 2018Key Biologics and Blood Centers of America Partner to Advance Cell Therapy and Regenerative Medicine
September 4, 2018 September 4, 2018Ampersand Invests in Management Buyout of Clinical Immunology Provider NEOMED-LABS from the NEOMED Institute
June 14, 2018 June 14, 2018Sarepta Therapeutics Enters into Long-term Strategic Manufacturing Partnership with Brammer Bio to Support Gene Therapy Development and Commercial Supply
June 4, 2018 June 4, 2018MolecularMD and Genoptix Enter into a Definitive Agreement to Market the MRDx® BCR-ABL Test, a Companion Diagnostic for Treatment-free Remission in Ph+ CML-CP Patients Treated with Tasigna®
March 26, 2018 March 26, 2018MedPharm Receives Growth Equity Investment from Ampersand Capital Partners